Member Exclusive

Novel epigenetic therapy to treat mantle cell lymphoma

Scientists at Bellvitge Biomedical Research Institute have developed a small molecule epigenetic drug, targeting HDAC6, which could slow down cell growth in mantle cell lymphoma.

Go to the profile of Jasmine Harris
Jun 13, 2018
0
0

Please sign in or register for FREE

Register to MedChemNet

MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.

Register

No comments yet.